DTL
FATE icon

Dynamic Technology Lab’s Fate Therapeutics FATE Stock Holding History

Dynamic Technology Lab’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,820
Closed -$467K – 1227
2022
Q3 		$467K Buy
+20,820
New +$602K 0.05% 653
2021
Q4 		– Sell
-10,410
Closed -$617K – 1234
2021
Q3 		$617K Buy
10,410
+4,220
+68% +$331K 0.07% 448
2021
Q2 		$537K Sell
6,190
-1,737
-22% -$140K 0.05% 560
2021
Q1 		$654K Buy
+7,927
New +$760K 0.07% 430
2020
Q3 		– Sell
-8,798
Closed -$302K – 1088
2020
Q2 		$302K Buy
+8,798
New +$262K 0.05% 664
2020
Q1 		– Sell
-27,025
Closed -$529K – 1130
2019
Q4 		$529K Buy
+27,025
New +$429K 0.08% 428
2019
Q2 		– Sell
-10,317
Closed -$181K – 1062
2019
Q1 		$181K Buy
+10,317
New +$163K 0.03% 845
2017
Q2 		– Sell
-21,654
Closed -$99K – 1105
2017
Q1 		$99K Buy
+21,654
New +$79.2K 0.02% 897

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dynamic Technology Lab's FATE Position: Q4 2022 in Review

Dynamic Technology Lab sold out of Fate Therapeutics (FATE) in Q4 2022, closing a stake of 20,820 shares — an estimated $467K sold.

Dynamic Technology Lab first reported a position in FATE in Q1 2017 and held it in 8 quarters. The position peaked at $654K in Q1 2021. 227 funds tracked by Wall St. Rank hold FATE as of Q4 2022.

  • Dynamic Technology Lab reported no remaining Fate Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Dynamic Technology Lab sold 20,820 Fate Therapeutics shares in Q4 2022, an estimated $467K.
  • Dynamic Technology Lab first reported a position in Fate Therapeutics in Q1 2017 and held it in 8 quarters.
  • Dynamic Technology Lab's Fate Therapeutics position peaked at $654K in Q1 2021.
  • 227 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2022.

Based on Dynamic Technology Lab's 13F filing for Q4 2022, filed 14 Feb 2023.